THC
15.7–18.4%
Catalog-reported value · not a batch result
CBD
0.3%
Catalog-reported value · not a batch result
G13 Blue Widow is a hybrid cannabis strain by NCGA with up to 18.4% THC. Known for its balanced effects combining body relaxation and mental uplift.
Where to buy G13 Blue Widow seeds ↓No effect, terpene, flavor or medical-use data specific to G13 Blue Widow has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
THC in this profile
Moderate Potency18.4% THC
Are you a cultivar breeder or genetics company?
Do you breed G13 Blue Widow? Discuss your catalog and profile with StrainCompass. Verification requires an ownership review.
About G13 Blue Widow
This hybrid strain brings a wave of creative and euphoric effects that promote happiness and relaxation, perfect for easing anxiety, depression, or pain, all while boasting a THC content of 18.4% for a solid, approachable potency. Dominated by terpenes like myrcene, caryophyllene, and limonene, it features a delightful berry, blueberry, and sweet flavor profile that makes every session feel like a fruity treat. G13 Blue Widow stands out for its balanced high that combines mental clarity with physical ease, credited to breeder NCGA for crafting a strain that's both flavorful and therapeutically versatile.
Where to Buy Seeds
Independent partner links. StrainCompass is an educational directory and does not sell or ship physical goods. We may earn an affiliate commission from qualifying third-party purchases.
Frequently Asked Questions about G13 Blue Widow
Is G13 Blue Widow an Indica, Sativa, or Hybrid?
G13 Blue Widow is classified as a hybrid cannabis strain.
What cannabinoid content is reported for G13 Blue Widow?
G13 Blue Widow: 18.4% THC and 0.3% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.